DOI QR코드

DOI QR Code

A Treatment of Basal cell Carcinoma on the Face of a Xeroderma Pigmentosum Patient: A Case Report

색소피부건조증 환자에서 발생한 안면부 기저세포암의 치료 증례 보고

  • Bae, Jaehyun (Department of Plastic and Reconstructive Surgery, Konkuk University Medical Center) ;
  • Jun, Dongkeun (Department of Plastic and Reconstructive Surgery, Konkuk University Medical Center) ;
  • Kim, Jeenam (Department of Plastic and Reconstructive Surgery, Konkuk University Medical Center) ;
  • Lee, Myungchul (Department of Plastic and Reconstructive Surgery, Konkuk University Medical Center) ;
  • Shin, Donghyeok (Department of Plastic and Reconstructive Surgery, Konkuk University Medical Center) ;
  • Lim, So Dug (Department of Pathology, Konkuk University Medical Center) ;
  • Choi, Hyungon (Department of Plastic and Reconstructive Surgery, Konkuk University Medical Center)
  • 배재현 (건국대학교병원 성형외과학교실) ;
  • 전동근 (건국대학교병원 성형외과학교실) ;
  • 김지남 (건국대학교병원 성형외과학교실) ;
  • 이명철 (건국대학교병원 성형외과학교실) ;
  • 신동혁 (건국대학교병원 성형외과학교실) ;
  • 임소덕 (건국대학교병원 병리학교실) ;
  • 최현곤 (건국대학교병원 성형외과학교실)
  • Received : 2020.03.09
  • Accepted : 2020.04.26
  • Published : 2020.05.31

Abstract

Xeroderma pigmentosum is a rare autosomal recessive disease, related to defects in DNA repair mechanism. It presents skin lesions on sun-exposed areas, leading to various skin cancer. Skin lesions can be treated with cryotherapy, skin resurfacing, 5-FU, Imiquimod, topical T4 endonuclease V, radiotherapy and genetic therapy, but invasive skin cancer should be treated by a surgery. We report a 12-year-old female xeroderma pigmentosum patient with recurrent basal cell carcinoma successfully treated by skin grafting. In that there is no cure for this disease, prevention and patient education is most important.

Keywords

References

  1. Lehmann J, Seebode C, Martens MC, Emmert S. Xeroderma Pigmentosum - Facts and Perspectives. Anticancer Res. 2018;38:1159-1164.
  2. Friedberg E. The discovery that xeroderma pigmentosum (XP) results from defective nucleotide excision repair. DNA Repair. 2004;3:183-195. https://doi.org/10.1016/j.dnarep.2003.10.007
  3. Black JO. Xeroderma Pigmentosum. Head Neck Pathol. 2016;10:139-144. https://doi.org/10.1007/s12105-016-0707-8
  4. Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet journal of rare diseases. 2011;6:70. https://doi.org/10.1186/1750-1172-6-70
  5. Lee JS, Kang HY, Lee ES, Kim YC. Two Cases o f Xeroderma Pigmentosum with Skin Cancer. Korean J Dermatol. 2005;43:233.
  6. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. Journal of medical genetics. 2011;48:168-176. https://doi.org/10.1136/jmg.2010.083022
  7. Kumar J. De Sanctis-Cacchione Syndrome. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2020.
  8. Mahindra P, DiGiovanna JJ, Tamura D, Brahim JS, Hornyak TJ, Stern JB, et al. Skin cancers, blindness, and anterior tongue mass in African brothers. Journal of the American Academy of Dermatology. 2008;59:881-886. https://doi.org/10.1016/j.jaad.2008.06.030
  9. Shah JP, Patel SG. American Cancer Society Atlas of Clinical Oncology, Cancer of the Head and Neck. BC Decker Inc, Hamilton, London. 2001:1:77-99.
  10. Chidzonga MM, Mahomva L, Makunike-Mutasa R, Masanganise R. Xeroderma pigmentosum: a retrospective case series in Zimbabwe. Journal of oral and maxillofacial surgery. 2009;67:22-31.
  11. Adam M, Ardinger H, Pagon R, Wallace S, Bean L, Stephens K, et al. Xeroderma Pigmentosum. GeneReviews. 2016.
  12. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48:168-176. https://doi.org/10.1136/jmg.2010.083022
  13. Kraemer KH, Lee M-M, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer: the xeroderma pigmentosum paradigm. Archives of dermatology. 1994;130:1018-1021. https://doi.org/10.1001/archderm.1994.01690080084012
  14. Sibar S, Findikcioglu K, Erdal AI, Barut I, Ozmen S. Technical Aspects and Difficulties in the Management of Head and Neck Cutaneous Malignancies in Xeroderma Pigmentosum. Arch Plast Surg. 2016;43:344-351. https://doi.org/10.5999/aps.2016.43.4.344
  15. Ghartimagar D, Ghosh A, Shrestha SR, Shrestha S, Thapa S, Narasimhan R, et al. Basal Cell Carcinoma in Cases with or without Xeroderma Pigmentosum. Journal of the Nepal Medical Association. 2017;56:432-437. https://doi.org/10.31729/jnma.3304
  16. Lehmann J, Schubert S, Emmert S. Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches. J Dtsch Dermatol Ges. 2014;12:867-872.
  17. Roseeuw D. The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum. Clinical and experimental dermatology. 2003;28:30-32. https://doi.org/10.1046/j.1365-2230.28.s1.10.x
  18. Cafardi JA, Elmets CA. T4 endonuclease V: review and application to dermatology. Expert opinion on biological therapy. 2008;8:829-838. https://doi.org/10.1517/14712598.8.6.829
  19. Fife D, Laitinen MA, Myers DJ, Landsteiner PB. Vismodegib Therapy for Basal Cell Carcinoma in an 8-Year-Old Chinese Boy with Xeroderma Pigmentosum. Pediatr Dermatol. 2017;34:163-165. https://doi.org/10.1111/pde.13080
  20. Son WI, Byeon JH. A Patient with Xeroderma Pigmentosum Developing Radioresistant Basal Cell Epithelioma. J Korean Soc Plast Reconstr Surg. 2003;30:101.
  21. Ozmen S, Uygur S, Eryilmaz T, Ak B. Facial resurfacing with a monoblock full-thickness skin graft after multiple malignant melanomas excision in xeroderma pigmentosum. J Craniofac Surg. 2012;23:1542-1543. https://doi.org/10.1097/SCS.0b013e31824e660e
  22. Lasso JM, Yordanov YP, Pinilla C, Shef A. Invasive basal cell carcinoma in a xeroderma pigmentosum patient: facing secondary and tertiary aggressive recurrences. Journal of Craniofacial Surgery. 2014;25:e336-e338. https://doi.org/10.1097/SCS.0000000000000596